Cultured diploid fibroblasts from patients with the nevoid basal cell carcinoma syndrome are hypersensitive to killing by ionizing radiation.

Nevoid basal cell carcinoma syndrome (NBCCS) is an autosomal dominant disease. About 20% of the gene carriers studied developed medulloblastoma before the age of 5 years. Clinical follow-up of these patients, treated with radiotherapy, revealed a predisposition to radiogenic basal cell carcinomas with an unusually short latent period of 6 months to 3 years. The authors have therefore cultured skin fibroblasts from 5 NBCCS patients and measured their radiosensitivity in terms of clonogenic survival. Our results showed that, compared with 6 normal controls, the NBCCS cells were hypersensitive to X-rays. The average D0 (the inverse of the slope of the survival curve) for the NBCCS cells was 98 rads, compared with 142 rads for the normal controls and 44 rads for an ataxia telangiectasia (AT) strain. The average D10 values (the dose required to reduce survival to 10%) were 258, 351, and 123 rads for the NBCCS, normal, and AT strains, respectively. Unscheduled DNA synthesis measurements showed that NBCCS cells were not defective in excision repair of X-ray-damaged DNA. Pulse labeling index measurements showed that NBCCS cells were abnormally inhibited in the initiation of DNA synthesis following X-irradiation. The mechanisms underlying the radiosensitivity of NBCCS differ in several respects from those of AT. NBCCS appears to be potentially a useful model for studying the cellular processes that are important in radiation carcinogenesis.

[1]  P. Deschavanne,et al.  Unusual sensitivity of two Cockayne's syndrome cell strains to both UV and γ irradiation , 1981 .

[2]  G. L. Chan,et al.  On the nature of oncogenic transformation of cells. , 1981, International review of cytology.

[3]  R. Painter,et al.  Radiosensitivity in ataxia-telangiectasia: a new explanation. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[4]  M. Ferguson-Smith,et al.  Studies on a new case of xeroderma pigmentosum (XP3BR) from complementation group G with cellular sensitivity to ionizing radiation. , 1980, Carcinogenesis.

[5]  R. Weichselbaum,et al.  X-ray sensitivity of fifty-three human diploid fibroblast cell strains from patients with characterized genetic disorders. , 1980, Cancer research.

[6]  C. Arlett,et al.  Survey of radiosensitivity in a variety of human cell strains. , 1980, Cancer research.

[7]  A. Knudson Persons at high risk of cancer. , 1979, The New England journal of medicine.

[8]  E. Friedberg,et al.  Human Diseases Associated with Defective DNA Repair , 1979 .

[9]  L. Becker,et al.  Multiple nevoid basal-cell carcinoma syndrome (Gorlin's syndrome): possible confusion with metastatic medulloblastoma. Case report. , 1979, Journal of neurosurgery.

[10]  R. Weichselbaum,et al.  X-ray sensitivity of diploid fibroblasts from patients with hereditary or sporadic retinoblastoma. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[11]  L. Strong Genetic and environmental interactions , 1977, Cancer.

[12]  B. Schoenberg Multiple primary neoplasms and the nervous system , 1977, Cancer.

[13]  Frederick P. Li Second malignant tumors after cancer in childhood , 1977, Cancer.

[14]  A. Meadows,et al.  Patterns of second malignant neoplasms in children , 1977, Cancer.

[15]  M. Paterson,et al.  Defective excision repair of γ-ray-damaged DNA in human (ataxia telangiectasia) fibroblasts , 1976, Nature.

[16]  A. Taylor,et al.  Ataxia telangiectasia: a human mutation with abnormal radiation sensitivity , 1975, Nature.

[17]  T. Waltz,et al.  Neurological involvement in the nevoid basal cell carcinoma syndrome. , 1971, Journal of neurosurgery.

[18]  R. Spiro,et al.  Radiation‐induced skin cancer of the head and neck , 1970, Cancer.

[19]  G. Bahr,et al.  Medulloblastoma--a review of prognosis and survival. , 1969, The British journal of radiology.

[20]  D. Stevanović Nevoid basal cell carcinoma syndrome. , 1967, Archives of dermatology.